| 05/19/2026 5:14 PM | 60 Degrees Pharmaceuticals (1946563) Issuer Francois Eric (1656125) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 05/18/2026 3:33 PM | 60 Degrees Pharmaceuticals (1946563) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 05/15/2026 3:02 PM | 60 Degrees Pharmaceuticals (1946563) Subject Knight Therapeutics Inc. (1756235) Filed by | Form SCHEDULE 13G/A | |
| 05/15/2026 11:21 AM | 60 Degrees Pharmaceuticals (1946563) Subject CVI Investments, Inc. (1649553) Filed by | Form SCHEDULE 13G/A | |
| 05/15/2026 7:11 AM | 60 Degrees Pharmaceuticals (1946563) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 05/13/2026 3:30 PM | 60 Degrees Pharmaceuticals (1946563) Subject INTRACOASTAL CAPITAL, LLC (1646799) Filed by | Form SCHEDULE 13G/A | |
| 03/20/2026 3:15 PM | 60 Degrees Pharmaceuticals (1946563) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/13/2026 4:17 PM | 60 Degrees Pharmaceuticals (1946563) Filer | Form 424B5 | |
| 03/13/2026 4:15 PM | 60 Degrees Pharmaceuticals (1946563) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/11/2026 4:25 PM | 60 Degrees Pharmaceuticals (1946563) Filer | Form 424B5 | |
| 03/02/2026 3:20 PM | 60 Degrees Pharmaceuticals (1946563) Filer | Form 424B5 | |
Get the Latest News and Ratings for SXTPW and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for 60 Degrees Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
|
| 02/12/2026 7:58 AM | 60 Degrees Pharmaceuticals (1946563) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/23/2026 4:20 PM | 60 Degrees Pharmaceuticals (1946563) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/08/2026 8:00 AM | 60 Degrees Pharmaceuticals (1946563) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/16/2025 4:41 PM | 60 Degrees Pharmaceuticals (1946563) Issuer DOW GEOFFREY S (1977231) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 12/12/2025 7:39 AM | 60 Degrees Pharmaceuticals (1946563) Issuer DOW GEOFFREY S (1977231) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/13/2025 12:31 PM | 60 Degrees Pharmaceuticals (1946563) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/07/2025 4:30 PM | 60 Degrees Pharmaceuticals (1946563) Subject INTRACOASTAL CAPITAL, LLC (1646799) Filed by | Form SCHEDULE 13G/A | |
| 11/07/2025 3:54 PM | 60 Degrees Pharmaceuticals (1946563) Subject CVI Investments, Inc. (1649553) Filed by | Form SCHEDULE 13G/A | |
| 10/10/2025 3:15 PM | 60 Degrees Pharmaceuticals (1946563) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/15/2025 3:38 PM | 60 Degrees Pharmaceuticals (1946563) Issuer DOW GEOFFREY S (1977231) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/09/2025 7:00 AM | 60 Degrees Pharmaceuticals (1946563) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 09/05/2025 3:20 PM | 60 Degrees Pharmaceuticals (1946563) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 08/14/2025 8:23 PM | 60 Degrees Pharmaceuticals (1946563) Issuer Landon Kristen (2053910) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 08/14/2025 8:23 PM | 60 Degrees Pharmaceuticals (1946563) Issuer Landon Kristen (2053910) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/14/2025 8:24 PM | 60 Degrees Pharmaceuticals (1946563) Issuer Landon Kristen (2053910) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/13/2025 1:45 PM | 60 Degrees Pharmaceuticals (1946563) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 07/18/2025 4:46 PM | 60 Degrees Pharmaceuticals (1946563) Subject INTRACOASTAL CAPITAL, LLC (1646799) Filed by | Form SCHEDULE 13G | |
| 07/18/2025 3:57 PM | 60 Degrees Pharmaceuticals (1946563) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 07/17/2025 3:57 PM | 60 Degrees Pharmaceuticals (1946563) Subject Orca Capital AG (2052389) Filed by | Form SCHEDULE 13G | |
| 07/17/2025 3:59 PM | 60 Degrees Pharmaceuticals (1946563) Subject Orca Capital AG (2052389) Filed by | Form SCHEDULE 13G/A | |
| 07/16/2025 7:49 AM | 60 Degrees Pharmaceuticals (1946563) Filer | Form 424B4 | |
| 07/15/2025 11:15 PM | 60 Degrees Pharmaceuticals (1946563) Filer | Form EFFECT | |
| 07/07/2025 4:23 PM | 60 Degrees Pharmaceuticals (1946563) Filer | Form S-1 Registration statement under Securities Act of 1933 | |
| 06/09/2025 4:23 PM | 60 Degrees Pharmaceuticals (1946563) Issuer DOW GEOFFREY S (1977231) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/05/2025 7:53 PM | 60 Degrees Pharmaceuticals (1946563) Issuer XU CHERYL (1976957) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |